EODData

MEMBERSHIP REGISTER LOG IN

FRA, I7G0: IPSEN SA SP.ADR 1/4/ EO 1

30 Sep 2025
LAST:

28.20

CHANGE:
 0.40		OPEN:
28.20		HIGH:
28.20		ASK:
0.00		VOLUME:
0
CHG(%):
1.44		PREV:
27.80		LOW:
28.20		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
30 Sep 2528.2028.2028.2028.200
29 Sep 2527.8027.8027.8027.800
26 Sep 2527.8027.8027.8027.800
25 Sep 2528.6028.6028.6028.600
24 Sep 2528.2028.2028.2028.200
23 Sep 2528.8028.8028.8028.800
22 Sep 2529.6029.6029.6029.600
19 Sep 2528.4028.4028.4028.400
18 Sep 2528.6028.6028.6028.600
17 Sep 2529.2029.2029.2029.200

COMPANY PROFILE

Name:IPSEN SA SP.ADR 1/4/ EO 1
About:Ipsen S.A. operates as a biopharmaceutical company worldwide. The company provides drugs in the areas of oncology, neuroscience, and rare diseases. Its product pipeline comprises Cabometyx + Atezolizumab, which is in phase III clinical trial for the treatment of second line metastatic castration-resistant prostate cancer; lenalidomide and rituximab, and Taverik, which is in phase III for the treatment of second line follicular lymphoma; Bylvay, which is in phase III for the treatment of biliary atresia; Dysport, which is in phase III clinical trial for the treatment of chronic and episodic migraine; Fidrisertib, which is in phase II clinical trial for the treatment of fibrodysplasia ossificans progressiva; Elafibranor, which is in phase II for the treatment of primary sclerosing cholangitis, as well as IPN60250; IPN10200, which is in phase II for the treatment of longer-acting neurotoxin aesthetics and therapeutics; IPN60210, which is in phase I clinical trial for the treatment of relapsed/refractory multiple myeloma; and IPN60260 for the treatment of Viral cholestatic disease and is in phase I clinical trial. The company also offers Somatuline, Decapeptyl, Cabometyx, Onivyde, Tazverik, and other oncology products; Dysport and other neurosciences products; and Bylvay, NutropinAq, Increlex, and Sohonos for rare diseases. The company was founded in 1929 and is based in Boulogne-Billancourt, France.
Sector:Healthcare
Address:65, quai Georges Gorse, Boulogne-Billancourt, France, 92100
Website:https://www.ipsen.com
ISIN:US4626292050
LEI:549300M6SGDPB4Z94P11

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

P/E Ratio:21.64
DivYield:0.05
Div/Share:1.40
Price to Book:2.27
Price to Sales:2.59
EBITDA:1.333B
Shares:330.76M
Market Cap:9.328B

TECHNICAL INDICATORS

MA5:28.12
MA10:28.52
MA20:29.03
MA50:28.21
MA100:26.97
MA200:26.98
STO9:22.22
STO14:18.18
RSI14:40.00
WPR14:-81.82
MTM14:-1.00
ROC14:-0.03
ATR:0.50
Week High:28.80
Week Low:27.80
Month High:30.00
Month Low:27.80
Year High:30.83
Year Low:22.78

RECENT DIVIDENDS

Date Amount
09 Jun 2025$0.34
31 May 2024$0.28
02 Jun 2023$0.27
31 May 2022$0.27